Home > Healthcare & Medical Devices > Orthopedic Digit Implants Market
Orthopedic Digit Implants Market size is expected to grow significantly from 2022 to 2028. These devices are designed for the replacement of a cartilage, joint, or bone due to deformity or damage. The rising product demand is on account of increasing instances of congenital disabilities and damage or loss of limbs. Orthopedic digit implants help with bone fixation and can be utilized for the replacement of articulating surfaces across different joints in the body. A patient could be experiencing pain in bones and joints, that could require repairing. In such cases, such implants are highly useful.
On the basis of type, the meta tarsal joint implant segment will account for a substantial share in the market through 2028. These procedures are in high demand for the treatment of hallux rigidus, which is also dubbed as stiff big toe. Meta tarsal joint implants make use of a two-piece, small implant for covering the missing or damaged articular cartilage in the MTP joint, where the base of the great toe meets the foot. Higher demand for the implant for the restoration of mobility to the bones is poised to propel the market growth in the coming years.
Based on material, the titanium segment is anticipated to register considerable share in the market during the forecast timeframe. This is mainly attributed to the numerous properties of titanium like high corrosion resistance, high strength, and low density. Additionally, the non-toxic and non-magnetic properties of the material are set to be useful for application in biomedical materials. There is also a considerable resemblance in the modulus of elasticity and coefficient of thermal expansion of titanium and human bone, which will drive segment growth during the forecast period.
North America orthopedic digit implants market is predicted to register lucrative growth up to 2028. This upsurge is owing to an escalating rise in product developments across the region. Considering an instance, in February 2021, Additive Orthopaedics secured the approval of the U.S. FDA for its 3D-printed Patient Specific Talus Spacer. The product is the first-of-its-kind implant for the treatment of AVN (avascular necrosis) of the ankle joint, as a device of humanitarian use.
Leading players in the market comprise Merete, Stryker, DePuy Synthes (Johnson & Johnson), LifeSciences Holdings, TEIJIN NAKASHIMA MEDICAL, Wright Medical. It is noteworthy that numerous orthopedic implant manufacturers are taking keen interest in the adoption of strategic initiatives comprising mergers, acquisitions, product developments, collaborations, and partnerships for consolidating their position in the market.
For instance, in August 2021, J&J’s DePuy Synthes launched the Inhance shoulder system, comprising stemmed and stemless implants, which enables surgeons to easily transition from the stemless to stemmed through the procedure if required. The integrated system has been designed for tackling an extensive range of cases, while maintaining a range of implant sizes.
The COVID-19 pandemic has brought about considerable alterations in the industry landscape, including surging shift towards web-based platforms and an escalated commitment to surgeon education. Numerous hospital settings have recorded an increase in resource allocation for meeting the increased training demand and adopting COVID-related safety measures. The industry is witnessing soaring efforts for supporting orthopedic surgeons with numerous practice models for meeting the increased requirement for trained healthcare professionals.
Market, By Product Type
Market, By Material
Market, By End-use
The above information is provided for the following regions and countries: